Please assess the completion status of the following clinical trial:

Trial Title: Inflammation and Corticosteroid Responsiveness in Severe Asthma

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~The final diagnosis of severe asthma will be made according to the screening steps we have set up. The definition will require the presence of one or both major criteria (treatment with continuous or near continuous oral corticosteroids and/or requirement for treatment with high dose inhaled steroids) and two minor criteria.~Patients who do not fit the criteria of severe asthma will not be entered into the study.~Age 18-60; both sexes.~For the investigation of fiberoptic bronchoscopy, other additional inclusion criteria will be imposed:~1. Post-bronchodilator FEV1 greater than 40% on the day of the bronchoscopy~2. No evidence of an exacerbation of asthma within the past 4 weeks.~3. Ability to cooperate with procedures~4. Ability to give consent~5. Current smokers, and ex-smokers with greater than 10 pack years history of smoking.~Exclusion criteria~Pregnancy or unreliable contraceptive measures in child-bearing woman. he bronchoscopist has determined the subject is clinically appropriate for bronchoscopy~-~Exclusion Criteria:~-

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Severe Asthma (Type: None): Patients under Steps 4/5 of Asthma Treatment - SIGN/BTS Guidelines
- Moderate Asthma (Type: None): Asthma patients on steps 2/3 of Asthma treatment according to SIGN/BTS Guidelines
- Mild Asthma (Type: None): Asthma patients on steps 1 of asthma treatment (steroid naive).

Based on this trial design, predict the completion outcome and termination type (if applicable).